1872382-47-2
基本信息
化合物UNC3866
N-[4-(1,1-二甲基乙基)苯甲酰基]-L-苯丙氨酰基-L-丙氨酰基-L-亮氨酰-N6,N6-二乙基-L-赖氨酰-L-丝氨酸甲酯
UNC3866
UNC 3866
UNC-3866
N-[4-(1,1-Dimethylethyl)benzoyl]-L-phenylalanyl-L-alanyl-L-leucyl-N6,N6-diethyl-L-lysyl-L-serine methyl ester
L-Serine, N-[4-(1,1-dimethylethyl)benzoyl]-L-phenylalanyl-L-alanyl-L-leucyl-N6,N6-diethyl-L-lysyl-, methyl ester
(3S,6S,9S,12S,15S)-Methyl 3-benzyl-1-(4-(tert-butyl)phenyl)-12-(4-(diethylamino)butyl)-15-(hydroxymethyl)-9-isobutyl-6-methyl-1,4,7,10,13-pentaoxo-2,5,8,11,14-pentaazahexadecan-16-oate
物理化学性质
| 沸点 | 1034.5±65.0 °C(Predicted) |
| 密度 | 1.129±0.06 g/cm3(Predicted) |
| 储存条件 | Sealed in dry,Store in freezer, under -20°C |
| 溶解度 | Soluble in DMSO |
| 酸度系数(pKa) | 13.39±0.46(Predicted) |
| 形态 | A crystalline solid |
| 颜色 | White to off-white |
安全数据
| 危险性符号(GHS) |  GHS07 |
| 警示词 | 警告 |
| 危险性描述 | H302-H315-H319-H335 |
| 防范说明 | P261-P305+P351+P338 |
UNC3866价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/08/19 | HY-100832 | UNC3866 UNC3866 | 1872382-47-2 | 2mg | 800元 |
| 2024/08/19 | HY-100832 | UNC3866 UNC3866 | 1872382-47-2 | 5mg | 1000元 |
| 2024/08/19 | HY-100832 | UNC3866 UNC3866 | 1872382-47-2 | 10mg | 1600元 |
常见问题列表
IC50: 66±1.2 nM (CBX7)
UNC3866, a potent antagonist of the methyl-lysine (Kme) reading function of the Polycomb CBX and CDY families of chromodomains. UNC3866 binds the chromodomains of CBX4 and CBX7 most potently with a K d of 100 nM for each, and is 6- to 18-fold selective versus seven other CBX and CDY chromodomains while being highly selective versus >250 other protein targets. UNC3866 inhibits PC3 cell proliferation, a known CBX7 phenotype, while UNC4219, a methylated negative control compound, has negligible effects. UNC3866 is a potent and cellularly active antagonist of PRC1 chromodomains. UNC3866 is the most potent ligand reported for CBX7 with a K d of 97±2.4 nM. UNC3866 is equipotent for CBX4, which is most similar to CBX7, while it is 18-, 6- and 12-fold selective for CBX4/7 over CBX2, -6 and -8, respectively. Additionally, UNC3866 is 65-fold selective for CBX4/7 over CDY1 and 9-fold selective for CBX4/7 over CDYL1b and CDYL2.